3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Mesothelioma
3
Solid Tumor
2
Mesothelioma, Malignant
2
Uveal Melanoma
1
Solid Tumor, Adult
1
Recurrence
1
MMR-D/MSI-H Colorectal Cancers
1
Lung Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Solid Tumor, Adult
1
Advanced Solid Tumor
1
Interventions
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Solid Tumor, Adult
×
niraparib
×
Other solid neoplasm
×
Clear all
NCT04972110
2025-10-30
ATTACC
Repare Therapeutics
Phase 1/2
Terminated
156 enrolled
19 charts